Esure Share Discussion Threads

[masurenguy] 04/11/2014 11:45

Q3 IMS due out tomorrow.

[dr biotech] 22/10/2014 17:08

A comment from the AA showing that premiums are beginning to rise is apparently behind todays gain.

[dr biotech] 22/10/2014 09:48

Can only imagine they were worried about the storm yesterday and not so concerned about it today. Does seem weird though.

[bikeaholic] 22/10/2014 09:34

This share is weird. It appears to be determined do the opposite from the rest of the market?

[bikeaholic] 17/10/2014 20:23

Do you live in a tent?

[thamestrader] 17/10/2014 20:18

Blimmin' 'eck! Beer must be expensive where you live.
I'm paying off the mortgage with mine.

[bikeaholic] 17/10/2014 09:54

Interim goody-bag due today! I'm going to blow mine on a half pint of real ale.

[dr biotech] 13/10/2014 09:26

Or perhaps not.

But is seems premiums may be hardening

[dr biotech] 10/10/2014 16:25

Hopefully yesterday was the bottom for this one. Only bright spot on another dreadful day.

[gutterhead] 27/9/2014 14:18

Jock
That's why its this price, great div stock, bargain

[gutterhead] 24/9/2014 06:08

Looks good value

[the jock] 20/9/2014 18:42

Insurance margins getting squeezed,can see all insurance companies drifting down shortly for a few months yet

[diku] 10/9/2014 21:14

RSI looking a bit oversold here....

[dr biotech] 08/9/2014 10:01

Presumably this is down to the potential scottish independence vote.

[gliderpilot2002] 06/9/2014 16:56

No one really knows the yield as we don't know what the final dividend will be. This is the first full year as a quoted company and the remarks about dividends at the interim were less bullish than at the year end, which I suspect is typical Esure caution.

[saltaire111] 03/9/2014 20:23

Just being lazy but could someojne please give me the divi yield on esure?

Ta.

Salty

[dr biotech] 03/9/2014 14:39

Seems like the xd coupled with a broker price downgrade has given us todays disappointing drop.

Hopefully will recover over the next couple of days, its a solid income play.

[bikeaholic] 06/8/2014 10:23

290 and I'm out.

[dr biotech] 04/8/2014 07:39

Looks decent enough to me. No surprises.

[gutterhead] 04/8/2014 07:13

Special dividend a nice surprise
Solid results from a well managed company.
I'm happy

[masurenguy] 04/8/2014 07:09

esure Group plc
Half Yearly Report
RNS Number : 0975O
04 August 2014

esure Group plc interim results for the six months ended 30 June 2014

Solid set of results reflecting a disciplined underwriting performance in difficult market conditions

Highlights

. Profit before tax up 0.4% to £57.1m (HY 2013: £56.9m)

. In-force policies up 2.1% to 1.974 million (FY 2013: 1.933 million)

. Gross written premiums down 1.9% to £260.4m (HY 2013: £265.4m)

. Combined operating ratio1 increased 1.3ppts to 90.9% (HY 2013: 89.6%) due primarily to severe weather events in Q1

. Additional services revenues ("ASR")2 flat at £51.0m (HY 2013: £51.0m);

. ASR, excluding Claims Income2, up 5.7% to £48.0m (HY 2013: £45.4m)

. Earnings per share3 up 2.7% to 10.9 pence (HY 2013: 10.6 pence)

. Interim dividend per share of 5.1p (HY 2013: 2.5p4), a payout ratio5 of 70% (HY 2013: 70%)

. Strong financial position with IGD6 coverage of 366%, after allowing for the interim dividend.

Peter Wood, Chairman of esure Group plc, commented: "The Group's solid performance in the first half of the year is testament to the approach taken by the executive team, led by Stuart Vann, focusing on disciplined underwriting in difficult market conditions. I am pleased to announce the Board has declared an interim dividend of 5.1 pence per share, representing a payout ratio of 70%. The interim dividend that has been declared is inclusive of a 20% special dividend and is consistent with the Board's approach in setting the interim dividend. As in 2013, a key consideration when setting the final dividend will be the Board's view on prospective premium growth and our ongoing commitment to returning excess capital to shareholders."

Stuart Vann, Chief Executive Officer of esure Group plc, commented: "The first half of 2014 has seen no let up in the competitive rating environment in both the motor and home markets. The Group remained disciplined in its approach to rating and volume which has contributed towards our solid performance. Our combined operating ratio of 90.9% is in line with guidance and has been achieved despite the severe weather events of Q1. This is the result of our approach to underwriting across both segments at this stage of the cycle. We continue to take a prudent approach to reserving and the Group's reserves remain in excess of 15% above our actuarial best estimate. We have continued to enhance our underwriting platform and customer experience in the first half of the year; these developments will play a key role in the delivery of our growth strategy, when market conditions permit."

[jbat] 28/7/2014 22:51

Yes. We know that insurance premiums are still a bit flabby round the edges so I'm not looking for miracles, just not a rerun of last year's idiocy!

[dr biotech] 28/7/2014 10:16

It did bounce off an intraday low of 250p, so trading wise that may be support. As you say though the results will carry more weight. I am not expecting anything dramatic either way - something along the lines of "good progress in a challenging market" and an interim the same as last year.

[jbat] 28/7/2014 09:58

Dr Biotech - everything being equal, I would agree with you. However, with interim results imminent and the probable shake-up they're likely to cause, it's more likely to be +25% or -25%!

[dr biotech] 25/7/2014 13:17

If I was to take notice of what I wrote three weeks ago this would be a good time to buy to make 10%....